Although overexpression of Kif5a did not increase RGC survival after injury, the conservation of RGC-enriched Kif5a expression across species suggests a strategy of manipulating Kif5a therapeutically to restore axonal transport after injury or in neurodegenerative diseases like glaucoma. This evidence concerns the gene KIF5A and neurodegenerative disease.